TransCode Therapeutics prices $3.0M public offering of 10M shares at $0.30

Transcode Therapeutics, Inc.

Offering of 10,000,000 common shares at $0.30 per share for gross proceeds of $3.0M.
Placement agent warrants to purchase 500,000 shares at $0.375, expiring July 22, 2029.
Expected close on July 24, 2024; proceeds for TTX-MC138 clinical trials and working capital.
ThinkEquity acting as sole placement agent; securities offered via effective S-3 shelf.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.